Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7): An Exploratory Analysis of a Randomised Controlled Trial
Lancet 2021 Apr 10;397(10282)1351-1362, KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, D Bonsall, P Cicconi, S Charlton, EA Clutterbuck, AM Collins, T Cox, TC Darton, C Dold, AD Douglas, CJA Duncan, KJ Ewer, AL Flaxman, SN Faust, DM Ferreira, S Feng, A Finn, PM Folegatti, M Fuskova, E Galiza, AL Goodman, CM Green, CA Green, M Greenland, B Hallis, PT Heath, J Hay, HC Hill, D Jenkin, S Kerridge, R Lazarus, V Libri, PJ Lillie, C Ludden, NG Marchevsky, AM Minassian, AC McGregor, YF Mujadidi, DJ Phillips, E Plested, KM Pollock, H Robinson, A Smith, R Song, MD Snape, RK Sutherland, EC Thomson, M Toshner, DPJ Turner, J Vekemans, TL Villafana, CJ Williams, AVS Hill, T Lambe, SC Gilbert, M Voysey, MN Ramasamy, AJ PollardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.